平特五不中

Dr. Ahmed Aoude

Academic title(s): 
  • Assistant professor
  • Director of the Orthopedic Research Lab, RI-MUHC
Dr. Ahmed Aoude
Contact Information
Email address: 
ahmed.aoude [at] mcgill.ca
Phone: 
514-934-1934, Ext. 42264
Department: 
Surgery
Division: 
Orthopaedic Surgery
Hospital title: 
Staff Orthopaedic Surgeon, MSK Oncology Surgeon
Orthopedic Spine Surgeon, Montreal General Hospital
Degree(s): 

MD, FRCSC, B.ENG, M.ENG

Location: 
Montreal General Hospital
Graduate supervision: 

Currently supervising students

Group: 
Currently Recruiting
M.Sc. Students
M.Sc. Non-Thesis projects
Ph.D. Students
Research areas: 
Regenerative Medicine
Surgical Oncology
Medical Technology
Areas of expertise: 
  • Oncology resections
  • Spine reconstructive surgery
Current research: 
  • Orthopaedics and Musculoskeletal Biomechanics
  • Medical Technologies
  • Mechanobiology
  • Improve Surgical Performance
  • /orl/about-us
Clinical Interests: 

Primary Bone Tumors, Soft Tissue Sarcomas, Spine Oncology, Degenerative Spine Disorders, Orthopaedic Trauma

Areas of interest: 
  • Clinical Outcomes
  • Surgical Innovation
  • Surgical Navigation
  • Medical Device Development and Design
Biography: 

Dr. Ahmed Aoude is an assistant professor in Orthopedic Surgery at 平特五不中. He completed fellowships in Orthopedic Oncology at Mount Sinai Hospital in Toronto and Spine Surgery at Foothills Medical Center in Calgary. His practice includes complex oncology resections and spine reconstructive surgery. Prior to medicine, Dr. Aoude obtained degrees in electrical engineering and biomedical engineering at 平特五不中. He also was a project manager designing and developing computer assisted surgery equipment and techniques for orthopedic surgery prior to pursuing his MD at University of Montreal. To date, he has multiple orthopedic surgery patents and many peer reviewed publications in orthopedics. His research interests include clinical outcomes and surgical techniques, as well as medical device development and design.

Selected publications: 

Follow us on:

Back to top